Using exercise to prevent cancer recurrence in high-risk patients
Exercise as Interception Therapy in Primary High Risk Cancer
This study is looking at whether exercise can help prevent cancer from coming back in people who have had early-stage breast, prostate, or colorectal cancer, by having them join structured exercise programs to see if staying active makes a difference in their recovery.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10894241 on NIH RePORTER |
What this research studies
This research investigates the potential of exercise therapy as a preventive measure for patients at high risk of cancer recurrence, particularly those with early-stage breast, prostate, and colorectal cancers. The approach involves implementing structured exercise interventions to see if they can reduce the likelihood of relapse after initial treatment. The study builds on previous observational data that suggests exercise may significantly lower relapse rates and aims to translate these findings into clinical practice. Patients will participate in exercise programs designed to enhance their physical activity levels and monitor the effects on their cancer outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with early-stage breast, prostate, or colorectal cancer who are at high risk for recurrence.
Not a fit: Patients with advanced metastatic cancer or those unable to participate in exercise due to severe health limitations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a non-invasive, accessible method to significantly reduce the risk of cancer recurrence in high-risk patients.
How similar studies have performed: Previous observational studies have shown promising results, indicating that exercise can reduce relapse rates in similar patient populations, suggesting that this approach may be effective.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Jones, Lee W — Sloan-Kettering Inst Can Research
- Study coordinator: Jones, Lee W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.